CZ121694A3 - Dermatological and cosmetic preparations - Google Patents
Dermatological and cosmetic preparations Download PDFInfo
- Publication number
- CZ121694A3 CZ121694A3 CZ941216A CZ121694A CZ121694A3 CZ 121694 A3 CZ121694 A3 CZ 121694A3 CZ 941216 A CZ941216 A CZ 941216A CZ 121694 A CZ121694 A CZ 121694A CZ 121694 A3 CZ121694 A3 CZ 121694A3
- Authority
- CZ
- Czechia
- Prior art keywords
- dermatological
- preparations according
- cosmetic preparations
- active ingredients
- emulsifying
- Prior art date
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title claims description 13
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 239000004480 active ingredient Substances 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 10
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 9
- 229930182558 Sterol Natural products 0.000 claims abstract description 7
- 229920001522 polyglycol ester Polymers 0.000 claims abstract description 7
- 239000008213 purified water Substances 0.000 claims abstract description 7
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 7
- 235000003702 sterols Nutrition 0.000 claims abstract description 7
- 229960000541 cetyl alcohol Drugs 0.000 claims abstract description 6
- 239000000194 fatty acid Substances 0.000 claims abstract description 6
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 5
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 5
- 229930195729 fatty acid Natural products 0.000 claims abstract description 5
- 150000003432 sterols Chemical class 0.000 claims abstract description 5
- 239000000022 bacteriostatic agent Substances 0.000 claims abstract description 4
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 4
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims abstract description 3
- 150000001298 alcohols Chemical class 0.000 claims abstract description 3
- 230000001804 emulsifying effect Effects 0.000 claims abstract description 3
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 claims description 10
- 229930003231 vitamin Natural products 0.000 claims description 8
- 239000011782 vitamin Substances 0.000 claims description 8
- 229940088594 vitamin Drugs 0.000 claims description 8
- 235000013343 vitamin Nutrition 0.000 claims description 8
- 102000016942 Elastin Human genes 0.000 claims description 6
- 108010014258 Elastin Proteins 0.000 claims description 6
- 239000006071 cream Substances 0.000 claims description 6
- 229920002549 elastin Polymers 0.000 claims description 6
- 150000004665 fatty acids Chemical class 0.000 claims description 5
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 5
- 102000008186 Collagen Human genes 0.000 claims description 4
- 108010035532 Collagen Proteins 0.000 claims description 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 4
- 229940121375 antifungal agent Drugs 0.000 claims description 4
- 239000003429 antifungal agent Substances 0.000 claims description 4
- 229920001436 collagen Polymers 0.000 claims description 4
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 4
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims description 4
- 239000003921 oil Substances 0.000 claims description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 230000000843 anti-fungal effect Effects 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 2
- -1 ampoules Substances 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 229940088710 antibiotic agent Drugs 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 229940088597 hormone Drugs 0.000 claims description 2
- 239000005556 hormone Substances 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 150000003611 tocopherol derivatives Chemical class 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 3
- 230000003712 anti-aging effect Effects 0.000 abstract description 2
- 230000001046 anti-mould Effects 0.000 abstract 1
- 239000002546 antimould Substances 0.000 abstract 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000007794 irritation Effects 0.000 description 3
- 239000000473 propyl gallate Substances 0.000 description 3
- 229940075579 propyl gallate Drugs 0.000 description 3
- 235000010388 propyl gallate Nutrition 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 208000035484 Cellulite Diseases 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 208000005230 Leg Ulcer Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- ZAKOWWREFLAJOT-ADUHFSDSSA-N [2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] acetate Chemical group CC(=O)OC1=C(C)C(C)=C2OC(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-ADUHFSDSSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- ALDITMKAAPLVJK-UHFFFAOYSA-N prop-1-ene;hydrate Chemical group O.CC=C ALDITMKAAPLVJK-UHFFFAOYSA-N 0.000 description 1
- OBSJFCPGRJMUDF-UHFFFAOYSA-N propyl 4-oxocyclohexa-1,5-diene-1-carboxylate Chemical class CCCOC(=O)C1=CCC(=O)C=C1 OBSJFCPGRJMUDF-UHFFFAOYSA-N 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Vynález se týká dermatologických a kosmetických přípravků, zvláště pak přípravků, které působí proti stárnutí; tyto přípravky lze rovněž použít při léčení spálenin a otevřených ran. Jsou vysoce stálé, což umožňuje jejich využití ke stabilizaci aktivních přísad.The invention relates to dermatological and cosmetic preparations, in particular to anti-aging preparations; they can also be used in the treatment of burns and open wounds. They are highly stable, allowing them to be used to stabilize the active ingredients.
Dosavadní stav technikvBACKGROUND OF THE INVENTION
Kůži tvoří buňky, jejichž stav ovlivňuje vnější vzhled epidermis. Stárnutí kůže nastává zpomalením jejích funkcí, zvláště pokud se týká výživy, dýchání, hydratace, regenerace a ochrany kožní tkáně. Stárnutí kůže je přirozený jev, jehož příčiny mají různý původ a který může být u každé osoby různě rychlý. Obvykle nastává snížení funkce určitých buněk, které jsou velmi důležité pro udržení neporušenosti struktury pokožky, přibližně ve třiceti letech. V závislosti na mnoha faktorech, jako je genetická výbava, celkový zdravotní stav nebo individuální způsob života může tento jev nastat i v dřívějším věku.The skin is made up of cells whose condition affects the external appearance of the epidermis. Aging of the skin occurs by slowing down its functions, especially as regards nutrition, breathing, hydration, regeneration and protection of skin tissue. Skin aging is a natural phenomenon whose causes have different origins and which can vary from person to person. Usually, there is a decrease in the function of certain cells, which are very important for maintaining the integrity of the skin structure, at about thirty years. Depending on many factors, such as genetic background, general health, or individual lifestyle, this phenomenon may occur at an earlier age.
Podstata vynálezuSUMMARY OF THE INVENTION
Předmětem předkládaného vynálezu jsou dermatologické a kosmetické prostředky, . účinné proti stárnutí a vysoce stabilní, a to i v přítomnosti aktivních přísad různého typu.The present invention relates to dermatological and cosmetic compositions. effective against aging and highly stable, even in the presence of active ingredients of various types.
Přípravek podle vynálezu se skládá z:The composition according to the invention consists of:
1) emulgačních a samoemulgačních činidel typu o/v (olej ve ·<··.1) O / W emulsifying and self - emulsifying agents (oil in.
vodě), tvořených směsí, která obsahuje (ve váhových %)water), consisting of mixtures containing (in weight%)
1') polyetylenglykol mono- nebo distearát 2') polyglykolové estery nasycených nebo nenasycených C14-C20 mastných kyselin 3') cetylalkohol a případně další vyšší alkoholy, kterými se rozumí volné či esterifikované steroly1 ') polyethylene glycol mono- or distearate 2') polyglycol esters of saturated or unsaturated C 14 -C 20 fatty acids 3 ') cetyl alcohol and optionally other higher alcohols, which are understood as free or esterified sterols
2) versenátu sodného a antioxidačních činidel2) sodium versenate and antioxidants
3) protiplísňových a bakteriostatických činidel3) antifungal and bacteriostatic agents
4) aktivních přísad4) active ingredients
0,5- 5,0 %0,5- 5,0%
1,0-10,01,0-10,0
1,0-16,0 0,1- 5,0 0,05-0,1 1,0-30,01,0-16,0 0,1- 5,0 0,05-0,1 1,0-30,0
5) přečištěné vody dle potřeby k doplnění do 100 %5) Purified water as needed to replenish up to 100%
Používané polyetylenglykoly mají různou molekulovou hmotnost, která se pohybuje od 200 do 10 000 a s výhodou od 400 do 2 000, zvláště se pak rovná hodnotě 1 000; přednost se dává zejména monostearátu polyetylenglykolu (1000) o této molekulové hmotnosti. ' 'The polyethylene glycols used have different molecular weights ranging from 200 to 10,000 and preferably from 400 to 2,000, especially equal to 1,000; particularly preferred is polyethylene glycol monostearate (1000) of this molecular weight. ''
Antioxidační činidla jsou volena ze skupiny, obsahující:The antioxidants are selected from the group consisting of:
a) nenasycené mastné kyseliny s vyšším počtem dvojných vazeb (polynenasycené); přednostně ty, které patří do skupiny vitaminu F(a) unsaturated fatty acids with a higher number of double bonds (polyunsaturated); preferably those belonging to the vitamin F group
b) tokoferylové deriváty, přednostně tokoferylacetát.b) tocopheryl derivatives, preferably tocopheryl acetate.
Příkladem protiplísňových nebo bakteriostatických činidel jsou methyl- či propyl-p-oxobenzoáty.Examples of antifungal or bacteriostatic agents are methyl or propyl p-oxobenzoates.
Aktivní přísady vykazují zejména aktivitu rekonstitující pokožku. Příkladem takových přísad, které se používají jednotlivě anebo ve vzájemné kombinaci, je kolagen v různých formách, esurosamin, elastin,' dále jsou to aminokyseliny, peptidy a mukopolysacharidy.In particular, the active ingredients exhibit skin reconstituting activity. Examples of such additives that are used singly or in combination with one another are collagen in various forms, esurosamine, elastin, amino acids, peptides and mucopolysaccharides.
Přípravky podle vynálezu se vyznačují významnou eudermicitou, tj. ve výjimečném rozsahu příznivě účinkují na napětí a hladkost kůže (působí proti vráskám), na průsvitnost pokožky, pevnost tkáně, otékavost a pružnost á na nepravidelné ukládání tuku do podkožního pojivá (celulitida). Stejně příznivé účinky mají přípravky na podráždění kůže u \ dětí, vyvolané mokrým ložním prádlem nebo potem, na podráždění nohou po promáčení i na podráždění způsobené sluněním.The preparations according to the invention are distinguished by significant eudermicity, i.e. they have an exceptionally beneficial effect on skin tension and smoothness (anti-wrinkle), on skin translucence, tissue firmness, swelling and elasticity and on irregular fat deposition in the subcutaneous binder (cellulite). Equally beneficial effects are on skin irritation in children caused by wet bedding or sweat, on irritation of the feet after soaking, and on irritation caused by sunbathing.
Přípravky podle vynálezu mají dále překvapivý dermatologický účinek na spáleniny, bércový vřed, hojení ran a proleženiny, nebot urychlují jejich léčení.Furthermore, the compositions of the invention have a surprising dermatological effect on burns, leg ulcer, wound healing and bedsores, since they speed up their treatment.
Zvláštní a překvapivou stránkou předkládaného vynálezu je skutečnost, že výše zmíněné přípravky, v úpravě vylučující aktivní činidla podle bodu 4), samy působí jako stabilisující nosiče vůči jednotlivým aktivním přísadám, jako jsou vitamíny, hormony či antibiotika. Proto jsou uváděné přípravky vhodné pro přípravu farmaceutických prostředků, obsahujících aktivní přísady, které jsou degradabilni vlivem vnějších podmínek (teplota, vlhkost, oxidující látky a pod.).A particular and surprising aspect of the present invention is the fact that the above-mentioned formulations, excreted as the excretory active agents of item 4), themselves act as stabilizing carriers against individual active ingredients such as vitamins, hormones or antibiotics. Therefore, the present compositions are suitable for the preparation of pharmaceutical compositions containing active ingredients which are degradable due to external conditions (temperature, humidity, oxidizing substances, etc.).
Různé testy stability, uskutečněné pomocí chromatografické analysy, potvrdily, že přípravky podle vynálezu udržují při pokojové teplotě titr přidaných aktivních přísad v nich obsažených ve stanoveném limitu; zvláště některé vitamíny vykazují pokles titru nepřevyšující během dvou let 10 %.Various stability tests carried out by means of chromatographic analysis have confirmed that the preparations according to the invention maintain at room temperature the titer of the active ingredients added therein within the specified limit; in particular, some vitamins show a decrease in titer not exceeding 10% over two years.
Přípravky podle vynálezu jsou připravovány v souhlase s postupy, ověřenými v dermatologii a kosmetice a mohou být ve formě krémů, emulsí, mlék, mazání, olejů, ampulí, masek, gelů, polštářků či sprejů.The compositions of the invention are formulated in accordance with dermatology and cosmetic validation procedures and may be in the form of creams, emulsions, lotions, ointments, oils, ampoules, masks, gels, pads or sprays.
Krémy i mléka mohou být, což představuje výhodu vynálezu, připravovány se stejnými složkami.Both creams and lotions can be formulated with the same ingredients as an advantage of the invention.
Testy snášenlivosti dermatologických a kosmetických přípravků podle předkládaného vynálezu potvrdily, že tyto přípravky jsou plně tolerovány a nepůsobí žádné podráždění, což prokazuje jejich vysokou eudermicitu. v ' \The tolerance tests of the dermatological and cosmetic compositions of the present invention have confirmed that these compositions are fully tolerated and do not cause any irritation, demonstrating their high eudermicity. in '\
Příklady provedeni vynálezuDETAILED DESCRIPTION OF THE INVENTION
Následující příklady dále ozřejmují vynález.The following examples further illustrate the invention.
Příklad 1Example 1
K přípravě 100 g základního krému přečištěná voda hammelisová voda cetylalkohol volné a esterifikované steroly methyl-p-oxybenzoát monostearát polyetylenglykolu (1 000) propy1-p-oxybenzoát propylgallát propylenglykol růžová esence versenát dvojsodný.To prepare 100 g of base cream purified water hammelis water cetyl alcohol free and esterified sterols methyl p-oxybenzoate polyethylene glycol monostearate (1000) propyl p-oxybenzoate propyl gallate propylene glycol pink essence versenate disodium.
vitamin F 80 % polyglykolové estery nasycených nebo nenasycených C14-C20 mastných kyselinvitamin F 80% polyglycol esters of saturated or unsaturated C 14 -C 20 fatty acids
Příklad 2Example 2
K přípravě 100 g elastinového krému elastin (bezvodý) kyselina linol-linoíová cetylalkohol monostearát polyetylenglykolu (1 000)For the preparation of 100 g of elastin cream elastin (anhydrous) linol linoleic acid cetyl alcohol polyethylene glycol monostearate (1000)
43,22 g 27,50 g 16,00 g43.22 g 27.50 g 16.00 g
1,00 g 0,15 g 3,00 g 0,05 g 0,03 g 7,00 g 0,25 g 0,05 g 1,25 g1.00 g 0.15 g 3.00 g 0.05 g 0.03 g 7.00 g 0.25 g 0.05 g 1.25 g
0,50 g0.50 g
- 2 g- 2 g
1.25 g 12,00 g1.25 g 12.00 g
2.25 g polyglykolové estery nasycených nebo nenasycených C14-C20 mastných kyselin volné a esterifikované steroly methyl-p-oxybenzoát propyl-p-oxybenzoát propylgallát sodná sůl kyseliny versenové hammelisová voda propylenglykol přečištěná voda růžová esence2.25 g polyglycol esters of saturated or unsaturated C 14 -C 20 fatty acids free and esterified sterols methyl p-oxybenzoate propyl p-oxybenzoate propyl gallate sodium versenic acid hammelis water propylene glycol purified water pink essence
Příklad 3Example 3
0,75 g 0,13 g 0,07 g 0,30 g 0,05 g0.75 g 0.13 g 0.07 g 0.30 g 0.05 g
20,50 g 5,25 g20,50 g 5,25 g
55,975-54,60 g 0,20 g55.975-54.60 g 0.20 g
K přípravě 100 g kolagenového krému:To prepare 100 g of collagen cream:
rozpustný kolagen (bezvodý) 1,20 g vitamin F (polynenasycené mastné kyseliny) 1,15 g elastin 0,50 g esurosamin 0,50 g vitamin E (tokoferylacetát) 0,20 g cetylalkohol 7,50 g monostearát polyetylenglykolu (1 000) 3,00 g polyglykolové estery nasycených nebo nenasycených ci4-c20 mastných kyselin 1,50 g volné a esterifikované steroly 1,50 g methyl-p-oxybenzoát 0,10 g propyl-p-oxybenzoát 0,01 g propylgallát 0,02 g sodná sůl kyseliny versenové 0,05 g esence Givaudan PCV-1845/2 0,30 g přečištěná voda 82,47 gsoluble collagen (anhydrous) 1.20 g vitamin F (polyunsaturated fatty acids) 1.15 g elastin 0.50 g esurosamine 0.50 g vitamin E (tocopheryl acetate) 0.20 g cetyl alcohol 7.50 g polyethylene glycol monostearate (1,000) 3.00 g polyglycol esters of saturated or unsaturated C 20 -C i4 fatty .gamma.CH acids 1.50 g free and esterified sterols 1.50 g methyl p-oxybenzoate 0.10 g propyl p-oxybenzoate 0.01 g propyl gallate 0 02 g versenic acid sodium salt 0.05 g essence Givaudan PCV-1845/2 0.30 g purified water 82.47 g
K přípravě 100 g čistícího mléka:To prepare 100 g of cleansing milk:
Příklad 4Example 4
Zastupuje:Represented by:
Claims (5)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI913127A IT1252061B (en) | 1991-11-22 | 1991-11-22 | COMPOSITIONS FOR DERMATOLOGICAL AND COSMETIC USE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CZ121694A3 true CZ121694A3 (en) | 1994-11-16 |
| CZ282574B6 CZ282574B6 (en) | 1997-08-13 |
Family
ID=11361168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ941216A CZ282574B6 (en) | 1991-11-22 | 1992-11-12 | Dermatological and cosmetic preparations |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5575994A (en) |
| EP (1) | EP0613367B1 (en) |
| JP (1) | JPH07501066A (en) |
| KR (1) | KR100218132B1 (en) |
| AT (1) | ATE129633T1 (en) |
| AU (1) | AU660738B2 (en) |
| BG (1) | BG61382B1 (en) |
| CA (1) | CA2123910A1 (en) |
| CZ (1) | CZ282574B6 (en) |
| DE (1) | DE69205839T2 (en) |
| DK (1) | DK0613367T3 (en) |
| HU (1) | HU214945B (en) |
| IT (1) | IT1252061B (en) |
| NO (1) | NO303564B1 (en) |
| RU (1) | RU2126243C1 (en) |
| SK (1) | SK279386B6 (en) |
| WO (1) | WO1993009760A2 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19501288A1 (en) * | 1995-01-18 | 1996-07-25 | Beiersdorf Ag | Lotions containing fatty acid derivatives |
| WO1996031192A1 (en) * | 1995-04-07 | 1996-10-10 | Kuyus-Stiftung | Cosmetic composition for treating cellulite |
| US7629384B2 (en) * | 1997-09-17 | 2009-12-08 | Strategic Science & Technologies, Llc | Topical delivery of L-arginine to cause beneficial effects |
| ITMI20021204A1 (en) * | 2002-06-04 | 2003-12-04 | Abiogen Pharma Spa | COMPOSITIONS CONTAINING DOLICOLO FOR DERMATOLOGICAL AND COSMETIC USE |
| RU2224534C1 (en) * | 2002-09-24 | 2004-02-27 | Общество с ограниченной ответственностью Парфюмерно-косметическая фирма Интеркосметика | Biologically active substance |
| JP4247758B2 (en) * | 2003-02-18 | 2009-04-02 | 日本光電工業株式会社 | Carbon dioxide gas sensor |
| US9226909B2 (en) | 2004-04-19 | 2016-01-05 | Strategic Science & Technologies, Llc | Beneficial effects of increasing local blood flow |
| JP4523388B2 (en) * | 2004-11-19 | 2010-08-11 | 日本メナード化粧品株式会社 | Collagen synthesis promoter and skin external preparation |
| IT1393422B1 (en) * | 2009-03-23 | 2012-04-20 | Nicoletti | COSMETIC COMPOSITION CONTAINING COLLAGEN AND ELASTIN |
| US11684624B2 (en) | 2009-06-24 | 2023-06-27 | Strategic Science & Technologies, Llc | Treatment of erectile dysfunction and other indications |
| US12138268B2 (en) | 2009-06-24 | 2024-11-12 | Strategic Science & Technologies, Llc | Treatment of erectile dysfunction and other indications |
| EP3045171A1 (en) | 2009-06-24 | 2016-07-20 | Strategic Science & Technologies, LLC | Topical composition |
| US20110082247A1 (en) * | 2009-10-06 | 2011-04-07 | Amcol International Corp. | Viscosity modified alcohols |
| JP2014501283A (en) | 2010-12-29 | 2014-01-20 | ストラテジック サイエンス アンド テクノロジーズ, エルエルシー | Systems and methods for the treatment of allergies and other indications |
| CN103429247A (en) | 2010-12-29 | 2013-12-04 | 战略科学与技术有限责任公司 | Treatment of erectile dysfunction and other indications |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1168949A (en) * | 1979-08-13 | 1984-06-12 | William G. Gorman | Cleansing compositions |
| EP0049354A3 (en) * | 1980-09-08 | 1983-02-23 | Sterling Drug Inc. | Composition for therapeutic virucidal use, and articles and packages containing said composition |
| US4474763A (en) * | 1982-07-07 | 1984-10-02 | Lubowe Irwin I | Skin preparation |
| LU84485A1 (en) * | 1982-11-22 | 1984-06-13 | Oreal | NOVEL ANTI-ACNE COMPOSITION BASED ON BENZOYL PEROXIDE AND AT LEAST ONE OTHER ACTIVE INGREDIENT |
| DE3304896A1 (en) * | 1983-02-12 | 1983-08-04 | Inge Rehberg | Preparation of an oil-in-water emulsion, which is stable on storage, for cosmetic purposes |
| GB2143841A (en) * | 1983-07-26 | 1985-02-20 | Wilkinson Sword Ltd | Soap compositions |
| US4695452A (en) * | 1984-10-10 | 1987-09-22 | Gannis Peter M | Cosmetic stick |
| US4883792A (en) * | 1989-01-17 | 1989-11-28 | Peter Timmins | Steroid cream formulation |
| IL95393A0 (en) * | 1989-08-18 | 1991-06-30 | John Morris Co | Odor-masked and stabilized compositions for treating keratinous tissue,skin conditions,and promoting wound healing |
| FR2688006A1 (en) * | 1992-02-27 | 1993-09-03 | Oreal | DISPERSION OF FLUORINATED HYDROCARBON IN AQUEOUS SOLUTION OF A FILMOGENIC POLYMER AND USE THEREOF FOR THE FORMATION OF COMPOSITE FILMS, ESPECIALLY IN COSMETICS. |
| ES2191664T5 (en) * | 1992-07-13 | 2008-02-16 | Shiseido Company, Ltd. | COMPOSITION FOR DERMATOLOGICAL PREPARATION. |
-
1991
- 1991-11-22 IT ITMI913127A patent/IT1252061B/en active IP Right Grant
-
1992
- 1992-11-12 AT AT92923386T patent/ATE129633T1/en not_active IP Right Cessation
- 1992-11-12 KR KR1019940701671A patent/KR100218132B1/en not_active Expired - Fee Related
- 1992-11-12 CZ CZ941216A patent/CZ282574B6/en not_active IP Right Cessation
- 1992-11-12 AU AU29296/92A patent/AU660738B2/en not_active Ceased
- 1992-11-12 JP JP5508960A patent/JPH07501066A/en active Pending
- 1992-11-12 SK SK583-94A patent/SK279386B6/en unknown
- 1992-11-12 DK DK92923386.4T patent/DK0613367T3/en active
- 1992-11-12 DE DE69205839T patent/DE69205839T2/en not_active Expired - Fee Related
- 1992-11-12 RU RU94027561A patent/RU2126243C1/en active
- 1992-11-12 WO PCT/EP1992/002597 patent/WO1993009760A2/en not_active Ceased
- 1992-11-12 HU HU9401533A patent/HU214945B/en not_active IP Right Cessation
- 1992-11-12 US US08/244,147 patent/US5575994A/en not_active Expired - Fee Related
- 1992-11-12 EP EP92923386A patent/EP0613367B1/en not_active Expired - Lifetime
- 1992-11-12 CA CA002123910A patent/CA2123910A1/en not_active Abandoned
-
1994
- 1994-05-10 BG BG98762A patent/BG61382B1/en unknown
- 1994-05-18 NO NO941855A patent/NO303564B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE129633T1 (en) | 1995-11-15 |
| DK0613367T3 (en) | 1996-02-26 |
| WO1993009760A2 (en) | 1993-05-27 |
| NO303564B1 (en) | 1998-08-03 |
| DE69205839D1 (en) | 1995-12-07 |
| CA2123910A1 (en) | 1993-05-27 |
| DE69205839T2 (en) | 1996-04-04 |
| ITMI913127A0 (en) | 1991-11-22 |
| KR100218132B1 (en) | 1999-09-01 |
| AU2929692A (en) | 1993-06-15 |
| WO1993009760A3 (en) | 1993-07-08 |
| BG98762A (en) | 1995-05-31 |
| US5575994A (en) | 1996-11-19 |
| SK58394A3 (en) | 1995-01-12 |
| EP0613367A1 (en) | 1994-09-07 |
| CZ282574B6 (en) | 1997-08-13 |
| SK279386B6 (en) | 1998-10-07 |
| JPH07501066A (en) | 1995-02-02 |
| RU2126243C1 (en) | 1999-02-20 |
| IT1252061B (en) | 1995-05-29 |
| BG61382B1 (en) | 1997-07-31 |
| NO941855L (en) | 1994-05-18 |
| HU9401533D0 (en) | 1994-09-28 |
| NO941855D0 (en) | 1994-05-18 |
| ITMI913127A1 (en) | 1993-05-22 |
| EP0613367B1 (en) | 1995-11-02 |
| HU214945B (en) | 1998-08-28 |
| HUT67861A (en) | 1995-05-29 |
| AU660738B2 (en) | 1995-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7307835B2 (en) | aqueous composition | |
| CZ121694A3 (en) | Dermatological and cosmetic preparations | |
| KR100775803B1 (en) | Skin composition containing coenzyme Q as an active ingredient | |
| CN101522266A (en) | Topical skin compositions, their preparation, and their use | |
| CA2509232A1 (en) | Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines | |
| US5358752A (en) | Skin care composition | |
| KR102301123B1 (en) | Cosmetic composition comprising retiniol steblized by mixed antioxidant | |
| RU2036637C1 (en) | Cosmetic remedy for regenerating faded skin | |
| RU2382635C1 (en) | Hand cream | |
| KR102489166B1 (en) | A cosmetic composition having excellent effect of improving skin tone, texture, blemish, luster and elasticity | |
| US11779527B2 (en) | Useful compositions for the cosmetic treatment of oily skin | |
| KR20230095381A (en) | Cosmetic composition comprising Actinidia fruit extract, actinidia flower extract and actinidia stem extract, and method for manufacturing the same | |
| US5190758A (en) | Sebaceous excitosecretory agent | |
| WO2017052678A1 (en) | Oily active pharmaceutical ingredient (api) for the treatment of skin conditions, compositions comprising same, and use thereof for preparing said compositions | |
| KR100355952B1 (en) | Skin Care Composition Containing Fish Cartilage Extract and Polypeptide Phytonadione | |
| KR100500172B1 (en) | Cosmetic Composition for Improving Skin Protection Comprising Human Epidermal Growth Factor and Lactokine as Active Ingredients | |
| KR100433373B1 (en) | Skin care composition containing human Epidermal Growth Factor | |
| JPH10130131A (en) | Oily transparent skin preparation for external use | |
| KR20010068548A (en) | Skin care composition containing Retinol and Tetradibutyl Pentaerithrityl Hydroxyhydrocinnamate | |
| KR20250035665A (en) | Cosmetic composition containing calcium palmitole β-sitosterol | |
| WO2019178658A2 (en) | Healing, moisturizing, humectant and emolient composition for topical administration in intertrigo skin lesions, skin lesions due to urinary and faecal incontinence and other related injuries. | |
| KR20140055156A (en) | Sitosterin improving skin aging or inflammation with protecting skin from external harmful materials such as ultraviolet ray etc | |
| PL167838B1 (en) | Cosmetic emulsions with hypoallergenic properties | |
| KR20140055154A (en) | Amygdalin improving skin aging or inflammation with protecting skin from external harmful materials such as ultraviolet ray etc |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| IF00 | In force as of 2000-06-30 in czech republic | ||
| MM4A | Patent lapsed due to non-payment of fee |
Effective date: 20011112 |